Selected research
Market Structure
Global In Vitro Skin Model Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global In Vitro Skin Model market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for In Vitro Skin Model is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for In Vitro Skin Model is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for In Vitro Skin Model is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for In Vitro Skin Model is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of In Vitro Skin Model include Alcyomics, Ashland, Creative Bioarray, Episkin, Epistem, Genoskin, MatTek, Phenion(Henkel) and REPROCELL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global In Vitro Skin Model market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of In Vitro Skin Model and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents In Vitro Skin Model sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the In Vitro Skin Model market size, projected growth trends, production technologies, key applications, and end-use industries.
In Vitro Skin Model Segment by Company
Alcyomics
Ashland
Creative Bioarray
Episkin
Epistem
Genoskin
MatTek
Phenion(Henkel)
REPROCELL
Sigma-Aldrich
In Vitro Skin Model Segment by Type
Reconstructed Human Epidermis (RHE) Models
Full-Thickness or Skin Equivalent (SE) Models
Others
In Vitro Skin Model Segment by Application
Medical Testing
Cosmetic Testing
Others
In Vitro Skin Model Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In Vitro Skin Model market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of In Vitro Skin Model and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In Vitro Skin Model.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the In Vitro Skin Model market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In Vitro Skin Model manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of In Vitro Skin Model in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of In Vitro Skin Model in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Reconstructed Human Epidermis (RHE) Models
- Full-Thickness or Skin Equivalent (SE) Models
- Others
Applications
- Medical Testing
- Cosmetic Testing
- Others
Companies covered
- Alcyomics
- Ashland
- Creative Bioarray
- Episkin
- Epistem
- Genoskin
- MatTek
- Phenion(Henkel)
- REPROCELL
- Sigma-Aldrich
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global In Vitro Skin Model Market Size, 2021 VS 2025 VS 2032
- 1.3 Global In Vitro Skin Model Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global In Vitro Skin Model Sales Estimates and Forecasts (2021-2032)
- 1.5 Global In Vitro Skin Model Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global In Vitro Skin Model Market Dynamics
- 2.1 In Vitro Skin Model Industry Trends
- 2.2 In Vitro Skin Model Industry Drivers
- 2.3 In Vitro Skin Model Industry Opportunities and Challenges
- 2.4 In Vitro Skin Model Industry Restraints
3 In Vitro Skin Model Market by Manufacturers
- 3.1 Global In Vitro Skin Model Revenue by Manufacturers (2021-2026)
- 3.2 Global In Vitro Skin Model Sales by Manufacturers (2021-2026)
- 3.3 Global In Vitro Skin Model Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global In Vitro Skin Model Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global In Vitro Skin Model Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global In Vitro Skin Model Manufacturers, Product Type & Application
- 3.7 Global In Vitro Skin Model Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global In Vitro Skin Model Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 In Vitro Skin Model Players Market Share by Revenue in 2025
- 3.8.3 2025 In Vitro Skin Model Tier 1, Tier 2, and Tier 3
4 In Vitro Skin Model Market by Type
- 4.1 In Vitro Skin Model Type Introduction
- 4.1.1 Reconstructed Human Epidermis (RHE) Models
- 4.1.2 Full-Thickness or Skin Equivalent (SE) Models
- 4.1.3 Others
- 4.2 Global In Vitro Skin Model Sales by Type
- 4.2.1 Global In Vitro Skin Model Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global In Vitro Skin Model Sales by Type (2021-2032)
- 4.2.3 Global In Vitro Skin Model Sales Market Share by Type (2021-2032)
- 4.3 Global In Vitro Skin Model Revenue by Type
- 4.3.1 Global In Vitro Skin Model Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global In Vitro Skin Model Revenue by Type (2021-2032)
- 4.3.3 Global In Vitro Skin Model Revenue Market Share by Type (2021-2032)
5 In Vitro Skin Model Market by Application
- 5.1 In Vitro Skin Model Application Introduction
- 5.1.1 Medical Testing
- 5.1.2 Cosmetic Testing
- 5.1.3 Others
- 5.2 Global In Vitro Skin Model Sales by Application
- 5.2.1 Global In Vitro Skin Model Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global In Vitro Skin Model Sales by Application (2021-2032)
- 5.2.3 Global In Vitro Skin Model Sales Market Share by Application (2021-2032)
- 5.3 Global In Vitro Skin Model Revenue by Application
- 5.3.1 Global In Vitro Skin Model Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global In Vitro Skin Model Revenue by Application (2021-2032)
- 5.3.3 Global In Vitro Skin Model Revenue Market Share by Application (2021-2032)
6 Global In Vitro Skin Model Sales by Region
- 6.1 Global In Vitro Skin Model Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global In Vitro Skin Model Sales by Region (2021-2032)
- 6.2.1 Global In Vitro Skin Model Sales by Region (2021-2026)
- 6.2.2 Global In Vitro Skin Model Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America In Vitro Skin Model Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America In Vitro Skin Model Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe In Vitro Skin Model Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe In Vitro Skin Model Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific In Vitro Skin Model Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific In Vitro Skin Model Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa In Vitro Skin Model Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa In Vitro Skin Model Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global In Vitro Skin Model Revenue by Region
- 7.1 Global In Vitro Skin Model Revenue by Region
- 7.1.1 Global In Vitro Skin Model Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global In Vitro Skin Model Revenue by Region (2021-2026)
- 7.1.3 Global In Vitro Skin Model Revenue by Region (2027-2032)
- 7.1.4 Global In Vitro Skin Model Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America In Vitro Skin Model Revenue (2021-2032)
- 7.2.2 North America In Vitro Skin Model Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe In Vitro Skin Model Revenue (2021-2032)
- 7.3.2 Europe In Vitro Skin Model Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific In Vitro Skin Model Revenue (2021-2032)
- 7.4.2 Asia-Pacific In Vitro Skin Model Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa In Vitro Skin Model Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa In Vitro Skin Model Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Alcyomics
- 8.1.1 Alcyomics Company Information
- 8.1.2 Alcyomics Business Overview
- 8.1.3 Alcyomics In Vitro Skin Model Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Alcyomics In Vitro Skin Model Product Portfolio
- 8.1.5 Alcyomics Recent Developments
- 8.2 Ashland
- 8.2.1 Ashland Company Information
- 8.2.2 Ashland Business Overview
- 8.2.3 Ashland In Vitro Skin Model Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Ashland In Vitro Skin Model Product Portfolio
- 8.2.5 Ashland Recent Developments
- 8.3 Creative Bioarray
- 8.3.1 Creative Bioarray Company Information
- 8.3.2 Creative Bioarray Business Overview
- 8.3.3 Creative Bioarray In Vitro Skin Model Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Creative Bioarray In Vitro Skin Model Product Portfolio
- 8.3.5 Creative Bioarray Recent Developments
- 8.4 Episkin
- 8.4.1 Episkin Company Information
- 8.4.2 Episkin Business Overview
- 8.4.3 Episkin In Vitro Skin Model Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Episkin In Vitro Skin Model Product Portfolio
- 8.4.5 Episkin Recent Developments
- 8.5 Epistem
- 8.5.1 Epistem Company Information
- 8.5.2 Epistem Business Overview
- 8.5.3 Epistem In Vitro Skin Model Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Epistem In Vitro Skin Model Product Portfolio
- 8.5.5 Epistem Recent Developments
- 8.6 Genoskin
- 8.6.1 Genoskin Company Information
- 8.6.2 Genoskin Business Overview
- 8.6.3 Genoskin In Vitro Skin Model Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Genoskin In Vitro Skin Model Product Portfolio
- 8.6.5 Genoskin Recent Developments
- 8.7 MatTek
- 8.7.1 MatTek Company Information
- 8.7.2 MatTek Business Overview
- 8.7.3 MatTek In Vitro Skin Model Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 MatTek In Vitro Skin Model Product Portfolio
- 8.7.5 MatTek Recent Developments
- 8.8 Phenion(Henkel)
- 8.8.1 Phenion(Henkel) Company Information
- 8.8.2 Phenion(Henkel) Business Overview
- 8.8.3 Phenion(Henkel) In Vitro Skin Model Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Phenion(Henkel) In Vitro Skin Model Product Portfolio
- 8.8.5 Phenion(Henkel) Recent Developments
- 8.9 REPROCELL
- 8.9.1 REPROCELL Company Information
- 8.9.2 REPROCELL Business Overview
- 8.9.3 REPROCELL In Vitro Skin Model Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 REPROCELL In Vitro Skin Model Product Portfolio
- 8.9.5 REPROCELL Recent Developments
- 8.10 Sigma-Aldrich
- 8.10.1 Sigma-Aldrich Company Information
- 8.10.2 Sigma-Aldrich Business Overview
- 8.10.3 Sigma-Aldrich In Vitro Skin Model Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Sigma-Aldrich In Vitro Skin Model Product Portfolio
- 8.10.5 Sigma-Aldrich Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 In Vitro Skin Model Value Chain Analysis
- 9.1.1 In Vitro Skin Model Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 In Vitro Skin Model Production Mode & Process
- 9.2 In Vitro Skin Model Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 In Vitro Skin Model Distributors
- 9.2.3 In Vitro Skin Model Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst